Medezine Holdings Ltd - Period Ending 2018-09-30
Medezine Holdings Ltd - Period Ending 2018-09-30
Registration number:
Medezine Holdings Ltd
for the Year Ended 30 September 2018
Heworth House
Melrosegate
Heworth
York
YO31 0RP
Medezine Holdings Ltd
Contents
Balance Sheet |
|
Notes to the Financial Statements |
Medezine Holdings Ltd
(Registration number: 09196257)
Balance Sheet as at 30 September 2018
Note |
2018 |
2017 |
|
Fixed assets |
|||
Investments |
|
|
|
Current assets |
|||
Debtors |
|
- |
|
Creditors: Amounts falling due within one year |
- |
( |
|
Net current assets/(liabilities) |
|
( |
|
Net assets |
|
|
|
Capital and reserves |
|||
Called up share capital |
|
|
|
Share premium reserve |
|
|
|
Profit and loss account |
|
|
|
Total equity |
|
|
For the financial year ending 30 September 2018 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
• |
|
• |
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts. |
These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.
These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.
Approved and authorised by the
......................................... |
......................................... |
Page 1 |
Medezine Holdings Ltd
Notes to the Financial Statements for the Year Ended 30 September 2018
General information |
The company is a private company limited by share capital, incorporated in England and Wales.
The address of its registered office is:
These financial statements were authorised for issue by the
Accounting policies |
Summary of significant accounting policies and key accounting estimates
The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.
Statement of compliance
These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A - 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.
Basis of preparation
These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.
Business combinations
Business combinations are accounted for using the purchase method. The consideration for each acquisition is measured at the aggregate of the fair values at acquisition date of assets given, liabilities incurred or assumed, and equity instruments issued by the group in exchange for control of the acquired, plus any costs directly attributable to the business combination. When a business combination agreement provides for an adjustment to the cost of the combination contingent on future events, the group includes the estimated amount of that adjustment in the cost of the combination at the acquisition date if the adjustment is probable and can be measured reliably.
Investments
Investments in equity shares which are publicly traded or where the fair value can be measured reliably are initially measured at fair value, with changes in fair value recognised in profit or loss. Investments in equity shares which are not publicly traded and where fair value cannot be measured reliably are measured at cost less impairment.
Interest income on debt securities, where applicable, is recognised in income using the effective interest method. Dividends on equity securities are recognised in income when receivable.
Share capital
Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.
Page 2 |
Medezine Holdings Ltd
Notes to the Financial Statements for the Year Ended 30 September 2018
Dividends
Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.
Investments |
2018 |
2017 |
|
Investments in subsidiaries |
|
|
Subsidiaries |
£ |
Cost or valuation |
|
At 1 October 2017 |
|
Provision |
|
Carrying amount |
|
At 30 September 2018 |
|
At 30 September 2017 |
|
Details of undertakings
Details of the investments in which the company holds 20% or more of the nominal value of any class of share capital are as follows:
Undertaking |
Registered office |
Holding |
Proportion of voting rights and shares held |
|
2018 |
2017 |
Subsidiary undertakings |
||||
|
Ordinary |
|
|
|
England and Wles |
The principal activity of Medezine Limited is |
The loss for the financial period of Medezine Limited was £190,883 and the aggregate amount of capital and reserves at the end of the period was £254,969. |
Debtors |
Note |
2018 |
2017 |
|
Amounts owed by group undertakings and undertakings in which the company has a participating interest |
|
- |
|
|
- |
Page 3 |
Medezine Holdings Ltd
Notes to the Financial Statements for the Year Ended 30 September 2018
Creditors |
Creditors: amounts falling due within one year
Note |
2018 |
2017 |
|
Due within one year |
|||
Amounts owed to group undertakings and undertakings in which the company has a participating interest |
- |
|
Share capital |
Allotted, called up and fully paid shares
2018 |
2017 |
|||
No. |
£ |
No. |
£ |
|
|
|
25 |
|
25 |
|
|
25 |
|
25 |
|
|
25 |
|
25 |
|
|
25 |
|
25 |
|
|
|
|
Page 4 |